Composition

Each Un-coated Tablet contains Glibenclamide I.P-5mg and Metformin Hcl I.P-500 mg

INDICATION

Type 2 Diabetes Management.

Packing

4*5*10 s Blister Packing.


Composition

Each Un-coated bilayer Tablet contains Gliclazide I.P-80Mg and Metformin Hcl I.P-500 mg.

INDICATION

Type 2 Diabetes Management.

Packing

10*10 s Blister Packing.


Composition

- Each Film coated Tablet contains Glimepiride I.P 1mg/2mg.

INDICATION

Type 2 Diabetes Management.

Packing

10*10s ALU ALU.


Composition

Each Un-coated Bilayer Tablet contains Glimepiride I.P 1mg/2mg and Metformin Hcl I.P -500mg in Sustained Release.

INDICATION

TYPE 2 Diabetes Management.

Packing

15*10s Blister Packing.


Composition

Each Un-coated Tablet contains Glimepiride I.P 2mg,Voglibose-0.2mg and Metformin Hcl I.P-500 mg.

INDICATION

TYPE 2 Diabetes Management.

Packing

10*10s Blister Packing.


Composition

Each Un-coated Tablet contains Metformin Hcl I.P 500mg

INDICATION

TYPE 2 Diabetes Management.
IN PCOS it increases the menstrual cyclicity and improves ovulation rates.

Packing

10*20s Blister Packing.


Composition

Each Un-coated Tablet contains Pioglitazone Hcl I.P 15mg

INDICATION

TYPE 2 Diabetes Management.

Packing

15*10s Blister Packing.


Composition

Each Un-coated Bilayer Tablet contains Pioglitazone Hcl I.P 15mg and Metformin Hcl I.P 500Mg in Sustained Release.

INDICATION

TYPE 2 Diabetes Management.

Packing

10*10s Blister Packing.


Composition

Each Un-coated Tablet contains Vildagliptn I.P 50mg/Metformin Hcl I.P 500 mg

INDICATION

TYPE 2 Diabetes Management

Packing

10*10s ALU ALU


Composition

Each Un-coated Tablet contains Voglibose0.2mg/0.3mg

INDICATION

TYPE 2Diabetes Management.
More in IGT.

Packing

10*10s ALU ALU.


Composition

Each Un-coated Tablet contains Voglibose0.2mg and Metformin Hcl I.P-500mg

INDICATION

TYPE 2 Diabetes Management

Packing

10*10s ALU ALU.